Browsing Category
Healthcare Industry News
2513 posts
Unilever to buy U.S. greens supplement company Grüns in latest wellbeing push
Unilever has agreed to acquire U.S. greens supplement brand Grüns in a deal valuing the three-year-old company at around $500 million. Read what it means for UL investors and the VMS market.
Why Four Corners Property Trust’s $4.4m National Veterinary Associates deal matters more than its size suggests
Four Corners Property Trust bought a National Veterinary Associates property for $4.4 million. Read why this small deal could matter for FCPT’s 2026 strategy.
Abbott hit with $70m Illinois verdict in premature infant formula case
Illinois jury awards $70 million against Abbott in a premature infant NEC formula case. Read what the Cook County verdict means now.
Why is Trinity’s Digital Twins launch more than just another generative AI product announcement for life sciences?
Trinity has launched Digital Twins for life sciences teams. Find out why this AI move could reshape pharma commercial strategy and market research.
Pearl launches Pearl Voice to push deeper into dental workflow automation
Pearl has launched Pearl Voice for dental documentation and charting. Read why this could reshape dental AI competition and practice workflow strategy.
Athena Security unveils ambulance bay weapons detection system as hospitals rethink emergency department security
Athena Security has launched an ambulance bay weapons detection system for hospitals. Read why this could reshape emergency department security workflows.
Can Lumos Diagnostics (ASX: LDX) turn a small Micro-Pak order into proof that its services model really scales?
Lumos Diagnostics has secured a new Micro-Pak manufacturing deal and first order. Read why this matters for ASX:LDX’s revenue mix and strategy.
Why Petwealth’s stealth debut could shake up preventive pet care faster than expected
Petwealth has launched with funding, PCR diagnostics, and new partnerships. Read how its platform strategy could reshape preventive pet care.
Archer Materials (AXE) advances Biochip to beta prototype as silicon-first strategy targets clinical validation
Archer Materials (ASX: AXE) advances its Biochip medical diagnostic to beta prototype, targeting clinical trials via silicon-first strategy and Stage 2 imec partnership. Read the full analysis.
Insight Health lands $11m to scale clinical AI agents across patient intake, triage, and documentation
Insight Health has raised $11 million to scale clinical AI agents for healthcare workflows. Read what this means for clinics, rivals, and AI health tech.